FDA Expands Approval of Drug to Stave Off Type 1 Diabetes
Summary
Teplizumab now indicated for kids as young as 1 year with preclinical disease
Description
Teplizumab now indicated for kids as young as 1 year with preclinical disease
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source